Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Analysts

MDP stock
Analysts Life Sciences mdp
Analyst loves this Canadian specialty pharma stock

Research Capital analyst Andre Uddin maintained his “Buy” rating and C$5.55 target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSX:MDP) following its fiscal third-quarter 2026 results. For the quarter ended December 31, 2025, Medexus reported total revenue of US$25.3-million, in line with Uddin’s estimate and broadly consistent with consensus, but down […]

CGY stock
Analysts cgy
This “Made in Canada” defense tech stock is a buy, analyst says

Ventum Capital Markets analyst Rob Goff raised his target on Calian Group (Calian Group Stock Quote, Chart, News, Analysts, Financials TSX:CGY) to C$84.00 from C$72.00 on February 12, maintaining his “Buy” rating following what he described as a return to “beat and raise” form. Ottawa-based Calian Group provides systems engineering and business and technology services […]

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

Byron Capital's Douglas Loe says the launch of Egrifta has been slower than expected, but should accelerate in 2012.

On Friday, Theratechnologies (TSX:TH) reported its Q1 2012 results. Revenue came in at $3.19-million...

Late in 2010, Calgary's VIQ Solutions signed a software licensing agreement with Cisco for its Encompass RPC product suite, which will be marketed along with Cisco's Connected Justice product portfolio.

Yesterday, VIQ Solutions (TSXV:VQS) reported its fiscal 2011 results. Revenue was up 25%, to $15.3-m...

Doug Gilmour

With top analysts like Tom Astle, Douglas Loe and Rob Goff, Toronto’s Byron Capital is known f...

ATS Automation

On April 2nd, the largest supply management association in the world, The Institute for Supply Manag...

Mood Media CEO Lorne Abony on CNBC Nov. 8, 2010. Byron Capital Telecom and Media analyst Rob Goff today initiated coverage on the company with a Strong Buy rating and a one year target of $5.60.

Byron Capital Telecom and Media analyst Rob Goff today initiated coverage on the company with a Stro...

M Partners analyst and sometime Cantech Letter contributor Ron Shuttleworth dropped by BNN’s s...

Zenn Motor founder Ian Clifford. Versant analyst Massimo Fiore says today's announced private placement is a

Zenn Motor (TSXV:ZNN) today announced it will raise $2-million in a non-brokered private placement, ...

AEterna Zentaris today announced its lead offering, Perifosine, failed to meet its primary endpoint. Byron Capital analyst Douglas Loe downgraded the stock and reduced his twelve-month target price.

Bad news for shareholders of AEterna Zentaris (TSX:AEZ) today as the company announced its lead offe...

Finavera CEO Jason Bak. Versant analyst Massimo Fiore says the company's stock is a buy at today's prices.

On Friday, Finavera Wind Energy (TSXV:FVR) received environmental approval for its 49.6-megawatt Tum...

Not here for the oranges: Versant Partners analyst Tom Liston says Wi-LAN has been particularly adept at using US

In early January, Ottawa’s Wi-LAN (TSX:WIN) opened a US office in Florida. Those who think CEO...

After the market close on Thursday, Research in Motion (TSX:RIM) will announce its Q4 2012 and full ...

Oncolytics Biotech CEO Brad Thompson. Byron Capital analyst Douglas Loe has a $9 target on the company's stock.

Last month, Calgary’s Oncolytics Biotech (TSX:ONC) completed a bought deal financing, raising ...

Last November, approximately forty people were injured at Jakarta's Pacific Place Mall when rumours spread a store there was low on the supply of the new BlackBerry Bold.

Last November, approximately forty people were injured at Jakarta’s Pacific Place Mall when ru...

Byron Capital healthcare analyst Douglas Loe believes that allergy treatment Oralair could become a leading product in Paladin Labs' already diverse offering.

Paladin Labs (TSX:PLB) yesterday announced it has received approval from Health Canada for it grass ...

Inside a full scale model interior of a Bombardier CSeries. Byron Capital analyst Tom Astle says the company's commercial aircraft business has been a drag on overall valuation, but may be improved by it recent deal with the Commercial Aircraft Corporation of China.

Bombardier (TSX:BBD.B) today provided some detail on the agreement it signed with the government own...

Some surprising news from Cardiome (TSX:COM) today as the company announced that Merck will disconti...

In a research update Tuesday, Versant analyst Tom Liston says a management shakeup at Wireless Matrix probably came about because of

A shuffle at Wireless Matrix (TSX:WRX) this week as the company announced that J. Richard Carlson, w...

Think border lineups are bad now? Without Waterloo's Descartes Systems they'd be a whole lot worse.

Descartes Systems Group (TSX:DSG) yesterday reported its fiscal 2012 results. Revenue was up 15% fro...

WELL Health
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
WEED stock

Here’s the problem with Canopy Growth stock

 February 13, 2026
OGI stock

Organigram. Buy, Sell or Hold?

 February 12, 2026
CURA stock

Curaleaf Holdings. Buy, Sell or Hold?

 February 11, 2026
SHOP stock

This analyst just upgraded Shopify

 February 11, 2026
MDA stock

Analyst raises target on MDA Space to street-high $60.00

 February 2, 2026